2005
DOI: 10.1157/13077752
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
10
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(10 citation statements)
references
References 10 publications
0
10
0
Order By: Relevance
“…The second individual showed positive reactions to diltiazem and verapamil (30% pet. ), whereas the third patient showed no cross‐reactivity . Two other case reports have described cross‐reactivity in patch testing between diltiazem (10% or 30% pet.)…”
Section: Discussionmentioning
confidence: 70%
See 2 more Smart Citations
“…The second individual showed positive reactions to diltiazem and verapamil (30% pet. ), whereas the third patient showed no cross‐reactivity . Two other case reports have described cross‐reactivity in patch testing between diltiazem (10% or 30% pet.)…”
Section: Discussionmentioning
confidence: 70%
“…There are more publications reporting cutaneous side‐effects after oral intake of diltiazem than cutaneous side‐effects after topical application . However, exclusively anecdotical observations have been published on cross‐reactivity of the pharmacologically different CCBs after oral intake.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Epicutaneous patch tests are useful for reinforcing the diagnosis of cutaneous adverse reactions to this drug (8–10). They are mainly performed with diltiazem “as is” preparations, diltiazem at 1%, 5%, 10%, 20%, and 30% in petrolatum preparations, diltiazem at 5%, 10%, 20%, and 30% in water preparations, and diltiazem at 30% in alcohol preparations (8–10).…”
Section: Discussionmentioning
confidence: 99%
“…Given the fact that in some instances the cutaneous lesions do not clinically improve after replacing the suspected calcium channel antagonist with a different one, cross‐reactions among these drugs are being considered (9, 10). Cholez et al divided calcium channel inhibitors into two main groups: dihydropirydines (nifedipine) and no‐dihydropirydines (verapamil and diltiazem) and considered cross‐reactions among drugs from different groups to be uncommon (9).…”
Section: Discussionmentioning
confidence: 99%